Cargando…

Prognostic Implications of PET-Derived Tumor Volume and Uptake in Patients with Neuroendocrine Tumors

SIMPLE SUMMARY: The monitoring of disease in patients with neuroendocrine tumors is challenging and requires specialized imaging techniques. To address these quests, somatostatin receptor-targeting molecular imaging modalities that can accurately visualize disease manifestations of neuroendocrine tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weber, Manuel, Telli, Tugce, Kersting, David, Seifert, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377105/ https://www.ncbi.nlm.nih.gov/pubmed/37509242 http://dx.doi.org/10.3390/cancers15143581

Ejemplares similares

Repeatability of (68)Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume
por: Seifert, Robert, et al.
Publicado: (2022)

Total tumor volume reduction and low PSMA expression in patients receiving Lu-PSMA therapy
por: Seifert, Robert, et al.
Publicado: (2021)

Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management
por: Roll, Wolfgang, et al.
Publicado: (2021)

Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors
por: Calabrò, Diletta, et al.
Publicado: (2020)

Prognostic Value of Volume-Based Parameters Measured by SSTR PET/CT in Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
por: Hou, Jiale, et al.
Publicado: (2021)

Clinicopathologic Features of Gastroenteropancreatic Neuroendocrine Tumors: A Single-center Experience
por: Akın Telli, Tuğba, et al.
Publicado: (2020)

Liver metastasis of a neuroendocrine tumor demonstrates intense uptake in PSMA-PET—but not its lymph-node metastasis and primary-tumor
por: Winter, Erik, et al.
Publicado: (2023)

Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors
por: Helgebostad, Rasmus, et al.
Publicado: (2022)

Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors
por: Altieri, Barbara, et al.
Publicado: (2020)

The Prognostic Value of Circulating Tumor Cells in Asian Neuroendocrine Tumors
por: Hsieh, Jason Chia-Hsun, et al.
Publicado: (2019)

PET metabolic tumor volume as a new prognostic factor in childhood rhabdomyosarcoma
por: Fayolle, Helio, et al.
Publicado: (2022)

Rubidium Uptake in Chest Tumors on PET/CT
por: Oldan, Jorge D., et al.
Publicado: (2022)

Neuroendocrine Tumors of the Lung
por: Fisseler-Eckhoff, Annette, et al.
Publicado: (2012)

Neuroendocrine tumors of the gallbladder
por: Niu, Chunyuan, et al.
Publicado: (2020)

Chemotherapy in Neuroendocrine Tumors
por: Das, Satya, et al.
Publicado: (2021)

FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate
por: Liu, Yiyan
Publicado: (2008)

(64)Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors
por: Mirzaei, Siroos, et al.
Publicado: (2019)

Prognostic significance of laterality in lung neuroendocrine tumors
por: La Salvia, Anna, et al.
Publicado: (2022)

PET-CT in Clinical Adult Oncology—VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors
por: Fine, Gabriel C., et al.
Publicado: (2022)

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors
por: Ehehalt, Florian, et al.
Publicado: (2010)

MON-250 Late Diagnosis of ACTH-secreting Pulmonary Neuroendocrine Tumor by Repeated (68)Ga Dotatate Pet/ct: Influence of Tumor Size in Abnormal Uptake?
por: Andrade, Natália Xavier S, et al.
Publicado: (2020)

Renal neuroendocrine tumors
por: Lane, Brian R., et al.
Publicado: (2009)

Neuroendocrine Tumors in Pediatrics
por: Farooqui, Zainab Azam, et al.
Publicado: (2019)

Neuroendocrine tumor theranostics
por: Ichikawa, Yasushi, et al.
Publicado: (2022)

Methodological evaluation of original articles on radiomics and machine learning for outcome prediction based on positron emission tomography (PET)
por: Rogasch, Julian Manuel Michael, et al.
Publicado: (2023)

Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors
por: Kubota, Kazuo, et al.
Publicado: (2014)

Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from (68)Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
por: Weber, Manuel, et al.
Publicado: (2020)

Gastrointestinal neuroendocrine tumors in 2020
por: Ahmed, Monjur
Publicado: (2020)

Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors
por: Chen, Hong-Yu, et al.
Publicado: (2020)

Long-term prognostic factors for PRRT in neuroendocrine tumors
por: Trautwein, Nils Florian, et al.
Publicado: (2023)

Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy
por: Handke, Analena, et al.
Publicado: (2023)

RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors
por: Wu, Yonghe, et al.
Publicado: (2016)

FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression
por: Vitali, Eleonora, et al.
Publicado: (2017)

Metabolic tumor volume and conformal radiotherapy based on prognostic PET/CT for treatment of nasopharyngeal carcinoma
por: Fei, Zhaodong, et al.
Publicado: (2019)

Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy
por: Zhou, Yuhang, et al.
Publicado: (2023)

Evaluation of thresholding methods for the quantification of [(68)Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [(177)Lu]Lu-PSMA-617 radioligand therapy
por: Kim, Moon, et al.
Publicado: (2023)

Management of Gastrointestinal Neuroendocrine Tumors
por: Wang, Rongzhi, et al.
Publicado: (2019)

The effects of molar activity on [(18)F]FDOPA uptake in patients with neuroendocrine tumors
por: Stormezand, Gilles N., et al.
Publicado: (2021)

Just another “Clever Hans”? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer
por: Weber, Manuel, et al.
Publicado: (2021)

Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients
por: Baeg, Kiwoon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b8s53mfngeb8ai7dc0n0ukq7cd